Navigation Links
Boehringer Ingelheim Awarded Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index

RIDGEFIELD, Conn., Nov. 18, 2015 /PRNewswire/ -- Boehringer Ingelheim announced today that it has been recognized on the 2016 Corporate Equality Index (CEI). This is the eighth time that the company received a perfect score and has been designated as a Best Place to Work for LGBT Equality. Administered by the Human Rights Campaign Foundation, the CEI is a national benchmarking report on corporate policies and practices related to workplace equality for lesbian, gay, bisexual and transgender employees.

"Our employees should always feel like they can bring their whole and true selves to work," said Nancy Di Dia, chief diversity and inclusion officer, Boehringer Ingelheim. "Providing a diverse and inclusive environment is a critical part of our culture. We strive for diversity of the individual, but also the diversity of ideas and experiences, which benefits our employees, and, ultimately, helps us to more effectively serve our broad patient population."

"In this 2016 Corporate Equality Index, hundreds of major businesses responded to our new standards for workplace equality with exceptional leadership," said Deena Fidas, workplace equality program director, Human Rights Campaign Foundation. "Boehringer Ingelheim not only meets these standards, it goes above and beyond the call of duty, making commitment to equality a fundamental aspect of its corporate values."

The 2016 CEI rated 1,027 businesses in the report, which evaluates LGBT-related policies and practices including non-discrimination workplace protections, domestic partner benefits, transgender-inclusive health care benefits, competency programs, and public engagement with the LGBT community. Boehringer Ingelheim's efforts in satisfying all of the CEI's criteria resulted in a 100 percent score. The company is among only 407 major U.S. businesses that earned top marks this year.

Boehringer Ingelheim's CEI perfect score is the latest accolade in a series of recent corporate award wins, including:

  • Thomson Reuters' Top 100 Global Innovators;
  • Science magazine's Top Employer list; and
  • Working Mother magazine's 100 Best Companies.

For more information on the 2016 Corporate Equality Index, or to download a free copy of the report, visit

About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.

Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with 146 affiliates and more than 47,000 employees. Since its founding in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine.

Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and families. Our employees create and engage in programs that strengthen our communities. To learn more about how we make more health for more people, visit our Corporate Social Responsibility Report.

In 2014, Boehringer Ingelheim achieved net sales of about $16.96 billion dollars (13.3 billion euros). R&D expenditure corresponds to 19.9 percent of its net sales.

For more information please visit, or follow us on Twitter @BoehringerUS.  

About the Human Rights Campaign
The Human Rights Campaign is America's largest civil rights organization working to achieve lesbian, gay, bisexual and transgender equality. By inspiring and engaging all Americans, HRC strives to end discrimination against LGBT citizens and realize a nation that achieves fundamental fairness and equality for all.

Boehringer Ingelheim Pharmaceuticals, Inc.
Name: Kate O'Connor
Phone: (203) 791-6250 

Photo -
Photo -  

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheim Announces Completed Enrollment of Phase III Clinical Trial for Biosimilar Candidate to Adalimumab
2. Global and USA Biosimilar Market: Get the latest updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim
3. Boehringer Ingelheim Highlights Latest Community and Research Initiatives in Advancing Anticoagulation Care at American Heart Association (AHA) Scientific Sessions 2015
4. Boehringer Ingelheim Recognized on Science Magazines 2015 Top Employer List
5. Boehringer Ingelheims investigational biologic cleared skin better, faster and for longer than ustekinumab in phase II psoriasis study
6. Investigation Report on Chinas Etanercept Market, 2019 Featuring Boehringer Ingelheim
7. Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas - Key Players are Roche, BMS, Sanofi, GSK, Boehringer Ingelheim, Celgene, Novartis and Pfizer
8. Phase I Data Published in The Lancet Show Boehringer Ingelheims Idarucizumab* Reverses Anticoagulant Effects of Dabigatran
9. FDA Approves Boehringer Ingelheims STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD
10. Boehringer Ingelheim and Sutter Health Establish Research Collaboration to Improve Patient Care
11. Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference
Post Your Comments:
(Date:1/8/2020)... ... January 08, 2020 , ... ... Medicare for medication-assisted treatment services at their Opioid Treatment Programs (OTPs) across ... medications, as well as counseling, began on January 1st. All BayMark branded ...
(Date:1/7/2020)... VEGAS (PRWEB) , ... January 07, 2020 , ... ... world’s first calibration-free blood pressure (BP) sensor system for integration in hearables and ... medical device and consumer electronics manufacturers for inclusion in their products. Embedded in ...
(Date:1/7/2020)... TORONTO (PRWEB) , ... January 06, 2020 , ... Myant ... that enable continuous and ambient heart health management at CES 2020 (January 7-10, Las ... as a winner in the Health & Wellness category of the CES 2020 Innovation ...
Breaking Medicine Technology:
(Date:1/7/2020)... ... January 07, 2020 , ... ... services, today identified six trends that will significantly impact the point of care ... the time shared between a provider and patient is the most important aspect ...
(Date:1/7/2020)... ... 2020 , ... Twenty-six people, all but one who live with Young Onset ... YOPD attend the 6th World Parkinson Congress. The participants, representing 11 countries , ... all 52 weeks in 2020. The group aims to raise at least $50,000 for ...
(Date:1/7/2020)... ... January 06, 2020 , ... A December 6 ... weight loss surgery and fewer complications including high blood pressure and premature birth before ... between their first and their second pregnancies were less likely to suffer adverse pregnancy ...
(Date:1/5/2020)... ... ... NJ Top Dentist, Dr. Irvin B. Sherman has been reviewed and approved ... teens and the special needs patient. The practice is located in Avon and Manasquan, ... Dr. Sherman and his practice will be addressing issues that mothers are having with ...
(Date:1/3/2020)... ... 2020 , ... Liz Barlowe, MA, CMC was recently elected ... Life Care Professionals® have advanced degrees and are experts in health and human ... with the family to provide recommendations for needed goods and services to enhance ...
Breaking Medicine News(10 mins):